MetaVia is trading at $1.18, up 5.36% after hours, with no clear company-specific catalyst identified. - This compares with the $1.12 regular-session close on October 30. - MetaVia’s Phase 1 DA-1726 presentation was announced October 28 for November 4, but available coverage does not link it to the rise. - The broader market was sharply weaker, which does not explain the stock’s move higher. After-hours volume details were not provided, and the cause remains unclear.